IPP Bureau
Merck FY20 sales up 8.6% euro 17.5 bn
By IPP Bureau - March 04, 2021
Merck forecasts organic growth of EBITDA pre in a high single-digit to low teens percentage range in 2021.
DSM increases price for polyamide 6 and 66 in EMEA
By IPP Bureau - March 02, 2021
The price increases are due to the rising costs of raw materials.
DSM secures victory in patent infringement litigation against Anhui Tiger
By IPP Bureau - March 02, 2021
Tiger can no longer make an important biotin intermediate using a DSM patented process.
Piramal Enterprises cashing in on opportunities: ICICI Securities
By IPP Bureau - March 02, 2021
PEL will explore the PLI scheme and apply if its beneficial.
Bayer delivers robust performance despite pandemic
By IPP Bureau - February 26, 2021
The company expects to generate an EBITDA margin before special items of around 27 percent in 2021.
India approves PLI scheme for pharmaceuticals
By IPP Bureau - February 26, 2021
Total incremental sales of Rs.2,94,000 crore and total incremental exports of Rs.1,96,000 crore are estimated during six years from 2022-23 to 2027-28.
Government allocates over Rs. 10,000 Cr in PLI scheme for bulk drugs and medical devices: Gowda
By IPP Bureau - February 26, 2021
The Govt. launched the PLI scheme for bulk drugs with a financial outlay of Rs 6,940 crores across 53 APIs over 6 years.
Granules India gets USFDA approval of acetaminophen, aspirin and caffeine tablets
By IPP Bureau - February 25, 2021
ranules now has a total of 38 ANDA approvals from US FDA.
Aurobindo Pharma to acquire 26% ownerships solar power companies
By IPP Bureau - February 24, 2021
The company will be holding 26% of the share capital in each of the solar power generating companies.
USFDA denies Sun Pharma Advanced Research’s appeal of NDA for Taclantis
By IPP Bureau - February 24, 2021
The company will review FDA's response and decide on appropriate next steps soon.
Thermo Fisher’s new facility in Bengaluru to produce reliable COVID-19 testing kits
By IPP Bureau - February 23, 2021
Applied Biosystems CoviPath COVID-19 RT-PCR Kit is approved for in vitro diagnostic use by ICMR and DCGI.
“Minus 20°C is sometimes trickier than minus 70°C”
By IPP Bureau - February 22, 2021
DHL and other logistics companies were already transporting pharmaceutical products at minus 70°C in Schaumaplast boxes packed with dry ice before the coronavirus pandemic
Unichem Laboratories receives ANDA approval for Apremilast Tablets
By IPP Bureau - February 20, 2021
Apremilast tablets are indicated for the treatment of adult patients with moderate to severe plaque psoriasis .
Zydus Cadila receives final approval from USFDA for Droxidopa capsules
By IPP Bureau - February 20, 2021
It is used to treat low blood pressure that causes severe dizziness or a lightheaded feeling.
Lupin receives approval for Droxidopa capsules
By IPP Bureau - February 20, 2021
Droxidopa Capsules, 100 mg, 200 mg, and 300 mg, are indicated for the treatment of orthostatic dizziness